News

Units of Paradigm Real Estate Investment Trust (KL:PARADIGM) were flat in their debut on the Main Market and remained largely ...
Paradigm Real Estate Investment Trust (Paradigm-REIT) began trading on the Main Market of Bursa Malaysia today, opening at ...
The assessment of Crohn's disease activity through endoscopy is a cornerstone of both clinical management and research. In The Lancet Gastroenterology & Hepatology, Christopher Ma and colleagues ...
Vineeth Gogineni is a Manager at Bain & Company, based in the Dallas office, serving private and public sector clients across ...
The prior article in the two-part series challenged the traditional view of economics as merely the management of scarce ...
Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...
When a retailer offers a chatbot to communicate with customers and solve their queries, or when a bank sends an SMS for ...
Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...
A new gene risk score, informed by machine learning, can predict weight-loss outcomes after Roux-en-Y gastric bypass surgery.
Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...
Bitcoin’s success reflects a growing shift in how the world approaches not only cryptocurrency but also financial markets as ...